Our team will be actively presenting at #ESCMID2026 showcasing key work in antimicrobial resistance (AMR), Gram-negative infections, and innovative clinical trial approaches.

📍 Join us from 17–21 April 2026 to connect, learn, and engage with us: ad-id.co/escmid26

Join the 5th Young Investigator Workshop at #ESCMID2026 in Munich!

🗓 Apr 19 | 🕤 09:30 CEST
🎟 Free for ticket holders + livestream

Learn, connect, and get inspired in clinical research 👇
www.ecraid.eu/articles/sig...

🫱🏼‍🫲🏻 We're proud to present the #PrIMAVeRaProject and our #perpetualobervationalstudies at the 7th @amr-accelerator.bsky.social Cross-Project Meeting held in Basel yesterday. We look forward to seeing everyone again at the PrIMAVeRa stakeholder meeting at #ESCMID2026!
@elskesieswerda.bsky.social

What an inspiring #ESCMIDGlobal2025 – packed with knowledge, connections, and fresh perspectives! 🌍✨ Looking forward to the next edition in beautiful Munich, April 2026. See you there! #ESCMID2026 #MunichAwaits

Fabulous talk @seanong.bsky.social Used BALANCE data developed & validated multi-variable risk scores which accurately predict outcome bacteramia. Showed results hold true across all risk groups. Paper: www.thelancet.com/journals/ecl...
#ESCMID2026
@steventong.bsky.social @drtoddlee.bsky.social